Research advance of selective inhibitor of tumornecrosis factor receptor
10.3969/j.issn.1006-0111.2015.05.003
- VernacularTitle:肿瘤坏死因子受体选择性拮抗剂的研究进展
- Author:
Hailong JIANG
1
;
Ningyuan WANG
;
Yiming LU
Author Information
1. 第二军医大学药学院微生物与生化药学教研室
- Keywords:
TNFR;
selective inhibition;
drug target
- From:
Journal of Pharmaceutical Practice
2015;(5):392-395
- CountryChina
- Language:Chinese
-
Abstract:
TNF signaling pathway was a valuable target ,and anti-TNF drugs were successfully used to treat autoim-mune and inflammatory diseases .But this therapy abrogate some beneficial TNF signaling ,leading to increased risk of infection and malignancy ,and the onset of new auto-immune diseases .Inhibiting the soluble TNF/TNFR1 axis while saving the benefi-cial transmembrane TNF/TNFR2 signaling untouched was a new approach .Because it inhibited the pathological effects of TNF and reduced the side effects ,and opened the way for the treatment of other diseases in which TNFR2 inhibition was detrimen-tal .The significance of the selective inhibition of TNFR1-mediated signaling pathways for TNF-related diseases was discussed and the mechanism of TNF identification TNFR was clarified ,which might provide new ideas for the design of new drugs .
